Baricitinib for Refractory Chronic Graft-Versus-Host Disease (cGVHD): Results of a Phase 1/2 Study

Autor:	Holtzman, Noa G., Im, Dr. Annie P., Ostojic, Alen, Curtis, Lauren M., Parsons-Wandell, Laura, Berman, Arlene, Nashed, Jeanette, Peer, Cody J., Reno, Annieka, Figg, William Douglas, Magone, M. Teresa, Cowen, Edward W., Mays, Jacqueline W., Hakim, Fran T., Rose, Jeremy J., Steinberg, Seth M., Pouzolles, Marie, Taylor, Naomi, Pavletic, Dr. Steven Z.
Zdroj:	Transplantation and Cellular Therapy; February 2023, Vol. 29 Issue: 2, Number 2 Supplement 1 pS251-S252, 2p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect